About Bioxcell Life Sciences Private Limited
Data last updated:
Bioxcell Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC082262. Its GSTIN is 36AAFCB1745F1ZX (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Karan Satyam and Parimala Karan Satyam.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at H.No: 22 – 71 Kanukunta R.C.Puram, Hyderabad, Telangana, India – 500019.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.74 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.92 Lakh (net margin 2.3%) and EBITDA of ₹7.78 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 10% over five years.
The company is associated with 2 brands: BioXcell Life Science and Bioxcell. As per MCA filings, the company has satisfied charges of ₹5 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioxcell.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressH.No: 22 – 71 Kanukunta R.C.Puram, Hyderabad, Telangana, India – 500019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bioxcell Life Sciences Private Limited
The main business activity of Bioxcell Life Sciences is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bioxcell Life Sciences Private Limited FY 2021 filings available
Bioxcell Life Sciences Private Limited reported revenue of ₹1.74 Cr (down 5% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Bioxcell Life Sciences Private Limited
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bioxcell Life Sciences Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.78 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.92 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bioxcell Life Sciences Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bioxcell Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atomes India Chemicals Private Limited | ₹1.77 Cr (FY 2024) | •••• | •••• | -46.0% | •••• | Coimbatore, Tamil Nadu, India |
| Citrus Life Sciences Private Limited | ₹1.76 Cr (FY 2023) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Trilogy Analytical Laboratory Private Limited | ₹1.75 Cr (FY 2021) | •••• | •••• | 25.0% | •••• | Hyderabad, Telangana, India |
| Mycelium Sona Biotech Private Limited | ₹1.75 Cr (FY 2025) | •••• | •••• | -62.0% | •••• | Bangalore, Karnataka, India |
| Toxiven Biotech Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | 238.0% | •••• | Coimbatore, Tamil Nadu, India |
| Bioxcell Life Sciences Private Limited this company | ₹1.74 Cr (FY 2021) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Cosmo Felix Private Limited | ₹1.73 Cr (FY 2024) | •••• | •••• | 53.0% | •••• | Delhi, India |
| KDR Crop Science Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Ahmedabad, Gujarat, India |
| Icrest Biotechnologies Limited | ₹1.68 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Bangalore, Karnataka, India |
| Hams Biotech Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | -42.0% | •••• | Chennai, Tamil Nadu, India |
| Srinidhi Biotech Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Gulbarga, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Bioxcell Life Sciences by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences Private Limited is audited by V S RAO & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V S RAO & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Karan Satyam | Director | 31 Jul 2012 | 14 Years 2 Months | Current |
| Parimala Karan Satyam | Director | 31 Jul 2012 | 14 Years 2 Months | Current |
Ownership and Shareholding of Bioxcell Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bioxcell Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2015 | Corporation Bank | ₹5 Lakh | Satisfied |
Total charge records: 1 View all charges
Legal Cases of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Ashv Finance Limited | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Ashv Finance Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ugro Capital Limited | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences operates two associated brands: BioXcell Life Science and Bioxcell. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures bio pesticides to support sustainable agricultural practices. | bioxcellifescience.in | |
| Biotechnology services and digital content management in India. | bioxcell.in |
Employees and EPFO Compliance at Bioxcell Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Bioxcell Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2012PTC082262. The current CIN is U24232TG2012PTC082262, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC082262 | Current |
| U24232AP2012PTC082262 | Previous |
Recent Activity on Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Parimala Karan Satyam was appointed as Director on 31 Jul 2012.
Credit Ratings, Litigation & Regulatory Alerts for Bioxcell Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bioxcell Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bioxcell Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCB1745F1ZX | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bioxcell Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioxcell Life Sciences Private Limited
Bioxcell Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 July 2012 (14+ years old) and is registered under CIN U24232TG2012PTC082262.
Bioxcell Life Sciences reported revenue of ₹1.74 Cr for FY 2021 (down 5% YoY).
Bioxcell Life Sciences has 2 current directors:
- Raj Karan Satyam - Director
- Parimala Karan Satyam - Director
Bioxcell Life Sciences reported a net profit of ₹3.92 Lakh (net margin 2.3%) and EBITDA of ₹7.78 Lakh (EBITDA margin 4.5%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bioxcell Life Sciences is -4% over three years and 10% over five years. In the latest year (FY 2021) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bioxcell Life Sciences is 36AAFCB1745F1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Bioxcell Life Sciences is U24232TG2012PTC082262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioxcell Life Sciences has 3 court cases on record: 3 filed against it. 1 is pending.
Bioxcell Life Sciences was incorporated on 31 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Bioxcell Life Sciences by revenue are Atomes India Chemicals Private Limited, Citrus Life Sciences Private Limited, Trilogy Analytical Laboratory Private Limited, Mycelium Sona Biotech Private Limited, Toxiven Biotech Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Parimala Karan Satyam was appointed as Director on 31 Jul 2012. Raj Karan Satyam was appointed as Director on 31 Jul 2012.